Correlation Between Emergent Biosolutions and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Neurocrine Biosciences, you can compare the effects of market volatilities on Emergent Biosolutions and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Neurocrine Biosciences.
Diversification Opportunities for Emergent Biosolutions and Neurocrine Biosciences
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Emergent and Neurocrine is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Emergent Biosolutions and Neurocrine Biosciences
Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 3.83 times more return on investment than Neurocrine Biosciences. However, Emergent Biosolutions is 3.83 times more volatile than Neurocrine Biosciences. It trades about 0.11 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.02 per unit of risk. If you would invest 739.00 in Emergent Biosolutions on August 31, 2024 and sell it today you would earn a total of 272.00 from holding Emergent Biosolutions or generate 36.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Emergent Biosolutions vs. Neurocrine Biosciences
Performance |
| Timeline |
| Emergent Biosolutions |
| Neurocrine Biosciences |
Emergent Biosolutions and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Emergent Biosolutions and Neurocrine Biosciences
The main advantage of trading using opposite Emergent Biosolutions and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.| Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Teva Pharma Industries | Emergent Biosolutions vs. Haleon plc |
| Neurocrine Biosciences vs. Emergent Biosolutions | Neurocrine Biosciences vs. Bausch Health Companies | Neurocrine Biosciences vs. Teva Pharma Industries | Neurocrine Biosciences vs. Haleon plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |